Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer

被引：0
|
作者：
Eun Kyoung Jeon
Hye-Sung Won
Yoon-Ho Ko
In Seok Lee
Tae Ho Hong
Young Kyoung You
Myung Ah Lee
机构：
[1] Seoul St. Mary’s Hospital,Division of Oncology, Department of Internal Medicine
[2] Catholic University,Division of Oncology, Department of Internal Medicine
[3] Uijeongbu St. Mary’s Hospital,Division of Gastroenterology, Department of Internal Medicine
[4] Catholic University,Department of Surgery
[5] Seoul St. Mary’s Hospital,undefined
[6] Catholic University,undefined
[7] Seoul St. Mary’s Hospital,undefined
[8] Catholic University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2012年 / 138卷
关键词：
Pancreatic cancer; Gemcitabine; Erlotinib; Capecitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1625 / 1630
页数：5
相关论文
共 50 条
  • [1] Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer
    Jeon, Eun Kyoung
    Won, Hye-Sung
    Ko, Yoon-Ho
    Lee, In Seok
    Hong, Tae Ho
    You, Young Kyoung
    Lee, Myung Ah
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (10) : 1625 - 1630
  • [2] Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer
    Muranaka, Tetsuhito
    Kuwatani, Masaki
    Komatsu, Yoshito
    Sawada, Kentaro
    Nakatsumi, Hiroshi
    Kawamoto, Yasuyuki
    Yuki, Satoshi
    Kubota, Yoshimasa
    Kubo, Kimitoshi
    Kawahata, Shuhei
    Kawakubo, Kazumichi
    Kawakami, Hiroshi
    Sakamoto, Naoya
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (03) : 566 - 571
  • [3] Efficacy and toxicity of gemcitabine-erlotinib in the metastatic pancreatic cancer treatment
    Mejia, L.
    Vicente, I.
    Lopez, M.
    Antonino, G.
    Garcia del Busto, N.
    Sanchez, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 989 - 989
  • [4] Gemcitabine in combination with capecitabine compared with gemcitabine combined with erlotinib in locally advanced or metastatic pancreatic cancer
    Khatri, P.
    Kumari, P.
    Beniwal, S.
    Samdariya, S.
    ANNALS OF ONCOLOGY, 2016, 27 : 92 - 92
  • [5] Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer
    Kulke, Matthew H.
    Blaszkowsky, Lawrence S.
    Ryan, David P.
    Clark, Jeffrey W.
    Meyerhardt, Jeffrey A.
    Zhu, Andrew X.
    Enzinger, Peter C.
    Kwak, Eunice L.
    Muzikansky, Alona
    Lawrence, Colleen
    Fuchs, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) : 4787 - 4792
  • [6] A PILOT TRIAL OF GEMCITABINE IN COMBINATION WITH CAPECITABINE OR ERLOTINIB COMPARED TO GEMCITABINE ALONE IN PATIENTS WITH ADVANCED PANCREATIC CANCER
    Cho, J. Y.
    Lim, J. Y.
    Lee, S. J.
    Lee, D. K.
    Park, J. S.
    Yoon, D. S.
    Min, Y. H.
    ANNALS OF ONCOLOGY, 2012, 23 : 240 - 240
  • [7] Comparison of the efficacy of gemcitabine with capecitabine and gemcitabine with erlotinib combination chemotherapy in recurrent or advanced pancreatic cancer as first-line treatment: Single-center experience
    Chun, S.
    Lee, M.
    Jeon, E.
    An, H.
    Hong, T.
    You, Y.
    Kim, D.
    Lee, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [8] EFFICACY AND POSSIBLE BIOMARKER OF GEMCITABINE AND ERLOTINIB FOR ADVANCED PANCREATIC CANCER
    Takahashi, Hideaki
    Kuwahara, Akiko
    Okuyama, Hiroyuki
    Ohno, Izumi
    Shimizu, Satoshi
    Mitsunaga, Shuichi
    Shinohara, Akira
    Kobayashi, Misaki
    Okusaka, Takuji
    Ikeda, Masafumi
    ANNALS OF ONCOLOGY, 2014, 25
  • [9] A Phase II Trial of Erlotinib in Combination With Gemcitabine and Cisplatin for Unresectable Pancreatic Cancer
    Hwang, I. G.
    Jang, J. S.
    Kang, J. H.
    Lee, G. W.
    Go, S. I.
    Kang, M. H.
    Oh, S. Y.
    Lee, S.
    Kwon, H. C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S461 - S461
  • [10] Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer
    Lim, Jae Yun
    Cho, Jang Ho
    Lee, Se Joon
    Lee, Dong Ki
    Yoon, Dong Sup
    Cho, Jae Yong
    CANCER RESEARCH AND TREATMENT, 2015, 47 (02): : 266 - 273
12345